Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

embolism/ожирение

Ссылка сохраняется в буфер обмена
Страница 1 от 961 полученные результаты

Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Obesity is a growing problem around the world, and radiology departments frequently encounter difficulties related to large patient size. Diagnosis and management of suspected venous thromboembolism, in particular deep venous thrombosis (DVT) and pulmonary embolism (PE), are challenging even in some

Perioperative rates of deep vein thrombosis and pulmonary embolism in normal weight vs obese and morbidly obese surgical patients in the era post venous thromboembolism prophylaxis guidelines.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND The increasing prevalence of obesity translates into a greater number of obese patients undergoing general surgery procedures. We questioned if increased awareness and recent prophylaxis guidelines impacted the incidence of venous thromboembolism (VTE) in the obese patients. METHODS A

Treatment of suspected pulmonary embolism in a morbidly obese patient.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
OBJECTIVE A case highlighting challenges with enoxaparin dosage and monitoring in obese patients is presented. CONCLUSIONS A morbidly obese 22-year-old Caucasian female (height, 168 cm; weight, 322 kg; body mass index [BMI], 114 kg/m2) who presented to the emergency department with acute-onset

Pulmonary embolism with myomatous erythrocytosis syndrome and extreme obesity.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
We here report a case of a 53-year-old woman requiring pulmonary embolectomy for acute massive pulmonary embolism caused by a huge uterine myoma compressing veins in the pelvis and extreme obesity. She was also diagnosed as having myomatous erythrocytosis syndrome, a rare disease associated with

Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Obesity is a well-established risk factor for pulmonary embolism (PE). However, treatment of PE in obese patients is challenging because of limited outcomes data, especially with advanced therapies such as catheter-based fibrinolysis. We assessed the efficacy and safety of ultrasound-facilitated,

Paradoxical embolism in morbidly obese persons.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Three cases of paradoxical embolism are reported in patients with morbid obesity. Early consideration of the possibility of paradoxical embolism allows the appropriate therapy to be instituted without delay. It appears that these patients are at increased risk for both pulmonary emboli and

Lipid Embolism in Obese Göttingen Minipigs.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Pigs are used as a model of human obesity, both for metabolic characterization and for evaluation of pharmacological interventions. Over a period of 7 years, acute death or clinical signs requiring immediate euthanasia were observed in 12 obese Göttingen minipigs (GMs) included in different

An Atypical Case of Morbid Obesity, Presenting With Deep Vein Thrombosis and Pulmonary Embolism

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Extreme obesity or Class III obesity is defined as a body mass index (BMI) greater than 40 kg/m2 and is invariably associated with a marked increase in morbidity and mortality. Our patient is a 36-year-old male wrestler, with a BMI of 63.53 kg/m2, and has been suffering from

Factor V leiden and morbid obesity in fatal postoperative pulmonary embolism.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
OBJECTIVE Currently, the risk for postoperative acute pulmonary embolism (APE) is assessed clinically. We hypothesize that the expensive screening for the most common genetic thrombophilic clotting defect (factor V Leiden; R(506)Q) after exclusion of established clinical risk factors does not offer

Emergency thromboembolectomy for impending paradoxical embolism through a patent foramen ovale owing to venous thromboembolism in a severely obese patient.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
A severely obese patient with dyspnea and weighing 197 kg presented to us. He experienced an impending paradoxical embolism in the left ventricle caused by a deep vein thrombosis passing through a patent foramen ovale, as well as an acute massive pulmonary thromboembolism. Emergency

Management of massive pulmonary embolism after jejuno-ileal bypass for morbid obesity.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Four patients developed massive pulmonary embolism after jejuno-ileal bypass for morbid obesity. All patients were in Greenfield's Class IV and were in shock. Severe hypoxia was evidenced in their blood gases. The patients were managed with digitalis, diuretics, Solu-Medrol (methylprednisolone

Treatment of pulmonary embolism in an extremely obese patient.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Low-molecular-weight heparins are effective as initial therapy for pulmonary embolism (PE) in a weight-based dosing regimen up to known body weights of 160 kg. The present case reports an extremely obese man of 252 kg (body mass index (BMI) 74 kg/m2) with PE who was treated with tinzaparin, dosed on

Brain Natriuretic Peptide and Troponin T in Patients With Acute Pulmonary Embolism and Grade 3 Obesity: A Retrospective Analysis

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Introduction The interpretation of brain natriuretic peptide (BNP) and Troponin T (TnT) in patients with obesity is very challenging. The applicability of these biomarkers as prognostic indicators of increased mortality in pulmonary embolism (PE) in patients with Grade 3 obesity has yet to be

Inferior vena cava filter placement for pulmonary embolism risk reduction in super morbidly obese undergoing bariatric surgery.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND Pulmonary embolism (PE) is a leading cause of mortality after bariatric surgery. We evaluated inferior vena cava (IVC) filter use for PE risk reduction in high-risk super morbidly obese bariatric surgery patients. METHODS IVC filters were inserted according to the patient's risk factors,

Evaluation of Time to Therapeutic Anticoagulation and Associated Outcomes in Critically Ill, Obese Patients With Pulmonary Embolism Receiving Unfractionated Heparin.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Delays in time to therapeutic activated partial thromboplastin time (aPTT) have been associated with poor outcomes in patients with acute pulmonary embolism (PE).To investigate the relationship between time to therapeutic anticoagulation and in-hospital
Присоединяйтесь к нашей
странице facebook

Самая полная база данных о лекарственных травах, подтвержденная наукой

  • Работает на 55 языках
  • Травяные лекарства, подтвержденные наукой
  • Распознавание трав по изображению
  • Интерактивная карта GPS - отметьте травы на месте (скоро)
  • Прочтите научные публикации, связанные с вашим поиском
  • Ищите лекарственные травы по их действию
  • Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов

Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.

Google Play badgeApp Store badge